特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
927207

精密医療 (プレシジョンメディシン) ソフトウェアの世界市場:2020年~2024年

Global Precision Medicine Software Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 147 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
精密医療 (プレシジョンメディシン) ソフトウェアの世界市場:2020年~2024年
出版日: 2020年01月21日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 147 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の精密医療 (プレシジョンメディシン)ソフトウェア市場は、2020年から2024年の予測期間中に11%のCAGRで成長し、8億8,265万米ドルの規模に達する見込みです。同市場は精密医療のメリットが主な成長要因となっています。また、医療のデジタル化によって、更に市場成長が促進される見通しです。

当レポートでは、世界の精密医療ソフトウェア (プレシジョンメディシン)市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 序文
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 2019年の市場規模
  • 市場の見通し
  • 市場規模と予測:2019-2024

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第6章 市場セグメンテーション:配信モード別

  • 市場セグメンテーション:配信モード別
  • 配信モード別比較:市場規模と予測2019-2024
  • オンプレミス
  • クラウドベース
  • 市場機会:配信モード別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模と予測2019-2024
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 発展途上国での臨床試験の増加
  • 医療のデジタル化
  • 新興国の医療およびITインフラストラクチャーの改善

第12章 ベンダー情勢

  • 概要
  • 情勢の革新
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics, Inc.
  • Gene42 Inc.
  • Human Longevity, Inc.
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • NantHealth Inc.
  • Roper Technologies Inc.
  • SOPHiA GENETICS SA
  • Syapse Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare technology market
  • Exhibit 02: Segments of global healthcare technology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key Offering
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Delivery mode - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by delivery mode
  • Exhibit 20: On-premise - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: On-premise - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Cloud-based - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Cloud-based - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by delivery mode
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 45: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 46: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 47: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 48: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 49: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 50: Fabric Genomics Inc. - Vendor overview
  • Exhibit 51: Fabric Genomics Inc. - Product segments
  • Exhibit 52: Fabric Genomics Inc. - Organizational developments
  • Exhibit 53: Fabric Genomics Inc. - Key offerings
  • Exhibit 54: Gene42 Inc. - Vendor overview
  • Exhibit 55: Gene42 Inc. - Organizational developments
  • Exhibit 56: Gene42 Inc. - Key offerings
  • Exhibit 57: Human Longevity Inc. - Vendor overview
  • Exhibit 58: Human Longevity Inc. - Organizational developments
  • Exhibit 59: Human Longevity Inc. - Key offerings
  • Exhibit 60: International Business Machines Corp. - Vendor overview
  • Exhibit 61: International Business Machines Corp. - Business segments
  • Exhibit 62: International Business Machines Corp. - Organizational developments
  • Exhibit 63: International Business Machines Corp. - Geographic focus
  • Exhibit 64: International Business Machines Corp. - Segment focus
  • Exhibit 65: International Business Machines Corp. - Key offerings
  • Exhibit 66: Koninklijke Philips NV - Vendor overview
  • Exhibit 67: Koninklijke Philips NV - Business segments
  • Exhibit 68: Koninklijke Philips NV - Organizational developments
  • Exhibit 69: Koninklijke Philips NV - Geographic focus
  • Exhibit 70: Koninklijke Philips NV - Segment focus
  • Exhibit 71: Koninklijke Philips NV - Key offerings
  • Exhibit 72: NantHealth Inc. - Vendor overview
  • Exhibit 73: NantHealth Inc. - Product segments
  • Exhibit 74: NantHealth Inc. - Organizational developments
  • Exhibit 75: NantHealth Inc. - Segment focus
  • Exhibit 76: NantHealth Inc. - Key offerings
  • Exhibit 77: Roper Technologies Inc. - Vendor overview
  • Exhibit 78: Roper Technologies Inc. - Business segments
  • Exhibit 79: Roper Technologies Inc. - Organizational developments
  • Exhibit 80: Roper Technologies Inc. - Geographic focus
  • Exhibit 81: Roper Technologies Inc. - Segment focus
  • Exhibit 82: Roper Technologies Inc. - Key offerings
  • Exhibit 83: SOPHiA GENETICS SA - Vendor overview
  • Exhibit 84: SOPHiA GENETICS SA - Product segments
  • Exhibit 85: SOPHiA GENETICS SA - Organizational developments
  • Exhibit 86: SOPHiA GENETICS SA - Key offerings
  • Exhibit 87: Syapse Inc. - Vendor overview
  • Exhibit 88: Syapse Inc. - Product segments
  • Exhibit 89: Syapse Inc. - Organizational developments
  • Exhibit 90: Syapse Inc. - Key offerings
  • Exhibit 91: Validation techniques employed for market sizing
  • Exhibit 92: Definition of market positioning of vendors
目次
Product Code: IRTNTR40844

Technavio has been monitoring the global precision medicine software market and it is poised to grow by USD 882.65 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. Our reports on global precision medicine software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by benefits of precision medicine.In addition, digitization of healthcare is anticipated to boost the growth of the global precision medicine software market as well.

Market Segmentation

Technavio's global precision medicine software market is segmented as below:

Delivery Mode:

  • On-premise
  • Cloud-based

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global precision medicine software market growth

This study identifies digitization of healthcare as the prime reasons driving the global precision medicine software market growth during the next few years.

Prominent vendors in global precision medicine software market

We provide a detailed analysis of around 25 vendors operating in the global precision medicine software market , including some of the vendors such as F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA and Syapse Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY DELIVERY MODE

  • Market segmentation by delivery mode
  • Comparison by delivery mode
  • On-premise - Market size and forecast 2019-2024
  • Cloud-based - Market size and forecast 2019-2024
  • Market opportunity by delivery mode

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rise in clinical trials in developing nations
  • Digitization of healthcare
  • Improvement in healthcare and IT infrastructure in emerging economies

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics, Inc.
  • Gene42 Inc.
  • Human Longevity, Inc.
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • NantHealth Inc.
  • Roper Technologies Inc.
  • SOPHiA GENETICS SA
  • Syapse Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.